These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9767372)

  • 1. Plasma acylation stimulating protein (ASP) as a predictor of impaired cellular biological response to ASP in patients with hyperapoB.
    Zhang XJ; Cianflone K; Genest J; Sniderman AD
    Eur J Clin Invest; 1998 Sep; 28(9):730-9. PubMed ID: 9767372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signal transduction pathway of acylation stimulating protein: involvement of protein kinase C.
    Baldo A; Sniderman AD; St Luce S; Zhang XJ; Cianflone K
    J Lipid Res; 1995 Jul; 36(7):1415-26. PubMed ID: 7595065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired response of fibroblasts from patients with hyperapobetalipoproteinemia to acylation-stimulating protein.
    Cianflone KM; Maslowska MH; Sniderman AD
    J Clin Invest; 1990 Mar; 85(3):722-30. PubMed ID: 2312723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ApoE phenotype influences plasma ASP in hyperapoB subjects.
    Cianflone K; Phélis S; Davignon J; Gilfix BM
    Atherosclerosis; 2003 Oct; 170(2):285-91. PubMed ID: 14612209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further insights into the pathophysiology of hyperapobetalipoproteinemia: role of basic proteins I, II, III.
    Kwiterovich PO; Motevalli M; Miller M; Bachorik PS; Kafonek SD; Chatterjee S; Beaty T; Virgil D
    Clin Chem; 1991 Mar; 37(3):317-26. PubMed ID: 2004437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic deficiency of acylation stimulating protein (ASP(C3ades-Arg)) does not cause hyperapobetalipoproteinemia in mice.
    Wetsel RA; Kildsgaard J; Zsigmond E; Liao W; Chan L
    J Biol Chem; 1999 Jul; 274(27):19429-33. PubMed ID: 10383458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coordinate regulation of triacylglycerol synthesis and glucose transport by acylation-stimulating protein.
    Germinario R; Sniderman AD; Manuel S; Lefebvre SP; Baldo A; Cianflone K
    Metabolism; 1993 May; 42(5):574-80. PubMed ID: 8492712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A critical evaluation of the putative role of C3adesArg (ASP) in lipid metabolism and hyperapobetalipoproteinemia.
    Kildsgaard J; Zsigmond E; Chan L; Wetsel RA
    Mol Immunol; 1999; 36(13-14):869-76. PubMed ID: 10698341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fasting and postprandial plasma concentrations of acylation-stimulation protein (ASP) in lean and obese Pima Indians compared to Caucasians.
    Weyer C; Pratley RE
    Obes Res; 1999 Sep; 7(5):444-52. PubMed ID: 10509601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathogenetic role of impaired fatty acid trapping by adipocytes in generating the pleiotropic features of hyperapoB.
    Sniderman AD; Cianflone K; Frayn K
    Diabetologia; 1997 Jul; 40 Suppl 2():S152-4. PubMed ID: 9248727
    [No Abstract]   [Full Text] [Related]  

  • 11. Acylation-stimulating protein (ASP): structure-function determinants of cell surface binding and triacylglycerol synthetic activity.
    Murray I; Köhl J; Cianflone K
    Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):41-8. PubMed ID: 10432298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma acylation-stimulating protein in coronary artery disease.
    Cianflone K; Zhang XJ; Genest J; Sniderman A
    Arterioscler Thromb Vasc Biol; 1997 Jul; 17(7):1239-44. PubMed ID: 9261252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acylation-stimulating protein (ASP) regulates glucose transport in the rat L6 muscle cell line.
    Tao Y; Cianflone K; Sniderman AD; Colby-Germinario SP; Germinario RJ
    Biochim Biophys Acta; 1997 Feb; 1344(3):221-9. PubMed ID: 9059512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional bioactive recombinant acylation stimulating protein is distinct from C3a anaphylatoxin.
    Murray I; Parker RA; Kirchgessner TG; Tran J; Zhang ZJ; Westerlund J; Cianflone K
    J Lipid Res; 1997 Dec; 38(12):2492-501. PubMed ID: 9458273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human acylation-stimulating protein and lipid biosynthesis in bovine adipose tissue explants.
    Jacobi SK; Miner JL
    J Anim Sci; 2002 Mar; 80(3):751-6. PubMed ID: 11890412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic response of Acylation Stimulating Protein to an oral fat load.
    Cianflone K; Vu H; Walsh M; Baldo A; Sniderman A
    J Lipid Res; 1989 Nov; 30(11):1727-33. PubMed ID: 2693569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adipsin system--acylation-stimulation protein (ASP) and hyperapo-B].
    Rato Q; Cianflone K; Sniderman A
    Rev Port Cardiol; 1996 May; 15(5):433-8, 366. PubMed ID: 8763517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ASP stimulates glucose transport in cultured human adipocytes.
    Maslowska M; Sniderman AD; Germinario R; Cianflone K
    Int J Obes Relat Metab Disord; 1997 Apr; 21(4):261-6. PubMed ID: 9130021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal protein tyrosine phosphorylation in fibroblasts from hyperapobetalipoproteinemia subjects.
    Motevalli M; Goldschmidt-Clermont PJ; Virgil D; Kwiterovich PO
    J Biol Chem; 1997 Sep; 272(39):24703-9. PubMed ID: 9305942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acylation stimulating protein (ASP), an adipocyte autocrine: new directions.
    Cianflone K; Maslowska M; Sniderman AD
    Semin Cell Dev Biol; 1999 Feb; 10(1):31-41. PubMed ID: 10355026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.